0
     

Report Added
Report already added
Biotechnology in China

Biotechnology in China

Summary

Biotechnology in China industry profile provides top-line qualitative and quantitative summary information including: market size (value 2015-19, and forecast to 2024). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Key Highlights

- The biotechnology market consists of the development, manufacturing, and marketing of products based on advanced biotechnology research.
- The Chinese biotechnology market had total revenues of $18.8bn in 2019, representing a compound annual growth rate (CAGR) of 5% between 2015 and 2019.
- The medical/healthcare segment was the market's most lucrative in 2019, with total revenues of $18.4bn, equivalent to 97.8% of the market's overall value.
- Compared with pharmas, biotech companies will have more difficulty compensating for supply chain disruptions from COVID-19, due to the high costs associated with their RandD.

Scope

- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the biotechnology market in China
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the biotechnology market in China
- Leading company profiles reveal details of key biotechnology market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the China biotechnology market with five year forecasts

Reasons to Buy

- What was the size of the China biotechnology market by value in 2019?
- What will be the size of the China biotechnology market in 2024?
- What factors are affecting the strength of competition in the China biotechnology market?
- How has the market performed over the last five years?
- What are the main segments that make up China's biotechnology market?

Table of Contents
1 Executive Summary
1.1. Market value
1.2. Market value forecast
1.3. Category segmentation
1.4. Geography segmentation
1.5. Market rivalry
1.6. Competitive Landscape
2 Market Overview
2.1. Market definition
2.2. Market analysis
3 Market Data
3.1. Market value
4 Market Segmentation
4.1. Category segmentation
4.2. Geography segmentation
5 Market Outlook
5.1. Market value forecast
6 Five Forces Analysis
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 Competitive Landscape
7.1. Who are the leading players?
7.2. What are the strengths of the leading players?
7.3. What strategies do leading players follow?
7.4. What was the rationale for recent M&A activity?
7.5. How might COVID-19 affect the competitive landscape?
8 Company Profiles
8.1. Sinovac Biotech Ltd.
8.2. Shanghai Kehua Bio-engineering Co Ltd
8.3. Novo Nordisk Pharmatech A/S
8.4. BeiGene Ltd
9 Macroeconomic Indicators
9.1. Country data
10 Appendix
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine

List of Tables
Table 1: China biotechnology industry value: $ billion, 2015-19
Table 2: China biotechnology industry category segmentation: $ billion, 2019
Table 3: China biotechnology industry geography segmentation: $ billion, 2019
Table 4: China biotechnology industry value forecast: $ billion, 2019-24
Table 5: Sinovac Biotech Ltd.: key facts
Table 6: Sinovac Biotech Ltd.: Annual Financial Ratios
Table 7: Sinovac Biotech Ltd.: Key Employees
Table 8: Shanghai Kehua Bio-engineering Co Ltd: key facts
Table 9: Shanghai Kehua Bio-engineering Co Ltd: Annual Financial Ratios
Table 10: Shanghai Kehua Bio-engineering Co Ltd: Key Employees
Table 11: Novo Nordisk Pharmatech A/S: key facts
Table 12: Novo Nordisk Pharmatech A/S: Key Employees
Table 13: BeiGene Ltd: key facts
Table 14: BeiGene Ltd: Annual Financial Ratios
Table 15: BeiGene Ltd: Key Employees
Table 16: BeiGene Ltd: Key Employees Continued
Table 17: China size of population (million), 2015-19
Table 18: China gdp (constant 2005 prices, $ billion), 2015-19
Table 19: China gdp (current prices, $ billion), 2015-19
Table 20: China inflation, 2015-19
Table 21: China consumer price index (absolute), 2015-19
Table 22: China exchange rate, 2015-19

List of Figures
Figure 1: China biotechnology industry value: $ billion, 2015-19
Figure 2: China biotechnology industry category segmentation: % share, by value, 2019
Figure 3: China biotechnology industry geography segmentation: % share, by value, 2019
Figure 4: China biotechnology industry value forecast: $ billion, 2019-24
Figure 5: Forces driving competition in the biotechnology industry in China, 2019
Figure 6: Drivers of buyer power in the biotechnology industry in China, 2019
Figure 7: Drivers of supplier power in the biotechnology industry in China, 2019
Figure 8: Factors influencing the likelihood of new entrants in the biotechnology industry in China, 2019
Figure 9: Factors influencing the threat of substitutes in the biotechnology industry in China, 2019
Figure 10: Drivers of degree of rivalry in the biotechnology industry in China, 2019

Report Title: Biotechnology in China


Your Details
Valid Invalid number

Companies Covered
Sinovac Biotech Ltd.
Shanghai Kehua Bio-engineering Co Ltd
Novo Nordisk Pharmatech A/S
BeiGene Ltd

SELECT A FORMAT

ADD TO CART BUY NOW